Navigation Links
Inhibitor That Blocks Host Receptors Found To be Effective In Treating Anthrax

A team of American and Canadian scientists from Rensselaer Polytechnic Institute in Troy, N.Y., and the University of Toronto have developed a new anthrax// inhibitor that blocks the host receptors where anthrax toxin attaches in the body.

The researchers said that the inhibitor was able to bind to multiple sites on the host receptor making it much for potent than the inhibitors that binds to single site. The researchers found that the new approach led to a 50,000-fold increase in activity to block multiple binding sites when compared with a more conventional inhibitor. They found that all six rats that got these inhibitors were protected against the toxins and had no adverse effects.

Anthrax is a serious disease caused by bacteria, Bacillus anthracis, which can affect both human and animals. The B. anthracis when inhaled, as when used as a biological weapon, is much more serious and can be fatal despite treatment with antibiotics. Most therapies including antibiotics used to treat anthrax are targeted against the bacteria or the toxin released by the bacteria that damages the host organism.

However, these bacteria can become resistant to antibiotics over time, and resistance can also be engineered intentionally into a germ as when used as a biological weapon. Also, the antibiotic used only slows the progression of infection, but do not counter the effects of the toxins once an infection takes hold.

However, the use of anthrax inhibitor could help address this issue as they block the receptor sites used by the bacteria to gain a lethal foothold in the body and thus can help reduce the number of deaths caused by inhaled anthrax once it is fully developed. According to the federal Centers for Disease Control and Prevention, inhaled anthrax still has a fatality rate of 75 percent even after antibiotics are given.

Ravi Kane, an associate professor of chemical and biological engineering at Rensselaer Polyte
'"/>




Page: 1 2

Related medicine news :

1. Aromatase Inhibitors drug Femara after Tamoxifen therapy protects from breast cancer recurrence
2. Macrophage Inhibitory Factor Causes Multiple Sclerosis Progression
3. Rejuvenation of Stem cells by GSK-3 Inhibitor
4. LipB Protein Inhibitors Help To Fight Against TB
5. Birth Defects Link With ACE Inhibitor Use, FDA Reports
6. Aromatase Inhibitors Better Than Tamoxifen For Treating Receptor-Positive Early Breast Cancer
7. ACE Inhibitors For Vascular Disease Patients
8. Reducing the Risk of Protease Inhibitor-Related Atherosclerosis
9. Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model
10. New Protein Inhibitor Halts Growth Of Cancerous Cells
11. Early Switch to an Aromatase Inhibitor Increases Survival
Post Your Comments:
(Date:7/7/2015)... ... 07, 2015 , ... Leading healthcare consulting firm Hammes Company ... Vice President, heading the firm’s Healthcare Advisory Services division. , Mr. Warden will ... providers’ needs in ways that strengthen their position in the marketplace. The Healthcare ...
(Date:7/7/2015)... ... ... a reputable source of authentic tickets for the 2015 CONCACAF Gold Cup Group A matches ... Stadium. , The 2015 CONCACAF Gold Cup is now upon us as Group A ... soil, will kick off in Frisco, CA from the Toyota Stadium and will feature two ...
(Date:7/7/2015)... ... July 07, 2015 , ... Greatist today announced the ... helps active people find the most fun activities to do with friends. , The ... It also increases Greatist’s opportunity for events, e-commerce, and brand partnerships. , “I’ve been ...
(Date:7/7/2015)... N.J. (PRWEB) , ... July ... ... CTLT), the leading global provider of advanced delivery technologies and development solutions ... signed an exclusive licensing agreement with Excelimmune, Inc. to access its antibody ...
(Date:7/7/2015)... ... July 07, 2015 , ... Healthpointe is ... team. Dr. Alupay, an anesthesiologist and pain management specialist, will be evaluating and treating ... as neurological conditions. , After receiving his Bachelor of Science in Biology from the ...
Breaking Medicine News(10 mins):Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3
... CHICAGO, Sept. 18 As economic, social and political ... state,s leading provider of addiction treatment services is expanding its ... afford expensive clinics but also fail to qualify for government-funded ... a 41-year-old non-profit organization, serves more than 29,000 patients in ...
... feelings of isolation remains unclear , FRIDAY, Sept. 18 (HealthDay ... suicide and rural communities that have higher numbers of bars. ... mean more suicides because it does not show cause and ... percent are alcoholics, according to background information in a news ...
... , SAN FRANCISCO, Sept. 18 VIA ... focused on the development of compounds for the treatment of ... 2009, it received a deficiency letter from the NASDAQ Stock ... the minimum $1.00 per share bid price requirement for continued ...
... , BROOMFIELD, Colo., Sept. 18 Accera, Inc., ... today announced today that it will present at the UBS Global ... , Steve Orndorff, Ph.D., founder, president and CEO, ... Axona (TM) on Monday, September 21 at 11:30 a.m. EDT. ...
... , , WASHINGTON, Sept. 18 ... plan by Senate Finance Chairman Max Baucus, DMLR Chairman Stuart L. ... "The plan released by Senator Baucus is inadequate in addressing the ... and Democrats in the Congress, health care policy experts, opinion leaders, ...
... , BELLEVUE, Wash., Sept. 18 ... today extended its Edifecs5010(TM) Compliance S ... Comparison Manual , a comprehensive version analysis resource that ... changes and includes valuable insights from Subject Matter Experts illuminating ...
Cached Medicine News:Health News:Gateway Responding To Increased Need for Treatment Among Middle-Income Substance Abusers 2Health News:Suicides Higher in Rural Areas With Bars 2Health News:VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ 2Health News:VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ 3Health News:VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ 4Health News:Accera, Inc. to Present at UBS Global Life Sciences Conference 2Health News:Statement From Stuart L. Weinstein, MD, Chairman, Doctors for Medical Liability Reform on Senator Baucus' Health Care Reform Proposal 2Health News:Edifecs Extends Its Edifecs5010(TM) Compliance Suite with the Launch of the Edifecs5010(TM) Comparison Manual, a Comprehensive Version Analysis Resource for HIPAA 5010 Migration. 2
(Date:7/7/2015)... The Global Breast Pumps Market is ... an estimated CAGR of 7.6% from 2014 to 2020, according ... of innovative technologies including hand free breast pumps, growing women ... advantages of breast milk are expected to drive breast pump ... untapped growth opportunities in emerging markets such as ...
(Date:7/7/2015)... China , July 7, 2015 /PRNewswire/ -- Mindray ... a leading developer, manufacturer and marketer of medical ... acquire the remaining stake in Wuhan Dragonbio Surgical ... Dragonbio is a domestic medical ... and other surgical products. Prior to today,s announcement, ...
(Date:7/7/2015)... July 7, 2015 EnteroMedics Inc. (NASDAQ: ... use neuroblocking technology to treat obesity, metabolic diseases, and ... announced public offering of 32,000,000 units. Each unit consists of ... warrant to purchase one share of common stock at ... purchase of units in the offering would result in ...
Breaking Medicine Technology:Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
... planned ECCE with peristaltic pump with ... suction, reflux possible with multi-function footswitch ... all critical functions. You can also ... actual vacuum level indicated by Bar ...
A wide selection of bipolar forceps and hemostatic erasers to facilitate most ophthalmic surgical procedures....
Medicine Products: